loadpatents
name:-0.0063810348510742
name:-0.0038509368896484
name:-0.0026180744171143
Tosh; David Patent Filings

Tosh; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tosh; David.The latest application filed is for "pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from ".

Company Profile
2.5.6
  • Tosh; David - Bath and North East Somerset GB
  • Tosh; David - Bath GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from
App 20190388463 - Kenyon; Julian Norman ;   et al.
2019-12-26
Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
Grant 10,350,239 - Kenyon , et al. July 16, 2
2019-07-16
Pharmaceutical Composition For Treating Cancer Comprising Trypsinogen And/or Chymotrypsinogen And An Active Agent Selected From A Selenium Compound, A Vanilloid Compound And A Cytoplasmic Glycolysis Reduction Agent
App 20180064753 - Kenyon; Julian Norman ;   et al.
2018-03-08
Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
Grant 9,636,359 - Kenyon , et al. May 2, 2
2017-05-02
Composition and method for differentiation of human embryonic stem cells
Grant 8,815,590 - Bone , et al. August 26, 2
2014-08-26
Composition And Method For Differentiation Of Human Embryonic Stem Cells
App 20130028872 - Bone; Heather K. ;   et al.
2013-01-31
Pharmaceutical Composition For Treating Cancer Comprising Trypsinogen And/or Chymotrypsinogen And An Active Agent Selected From A Selenium Compound, A Vanilloid Compound And A Cytoplasmic Glycolysis Reduction Agent
App 20120251516 - Kenyon; Julian Norman ;   et al.
2012-10-04
Transdifferentiation of cells and tissues
App 20060160218 - Slack; Jonathan ;   et al.
2006-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed